Avicanna Brings Medical Marijuana To Barbados With Rho Phyto Brand

Avicanna Inc. is a biopharmaceutical company that’s been focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products for quite some time. 

Now, the company is happy to announce it’s been working on expanding its Rho Phyto branded medical cannabis products into the Caribbean market. According to Global Newswire, Avicanna has partnered with distribution company Bryden Stokes Limited in Barbados to bring the initiative to life. 

Bryden Stokes is a renowned health and pharmaceutical product distributor in the Caribbean market, and Avicanna’s new partnership agreement with Bryden Stokes will help the company distribute its medical formulary Rho Phyto line of products into the Caribbean region. The initiative will begin with three product SKUs.

The new partnership will mark the 13th international market to which Avicanna’s many products have been exported. This also marks the third country that will have Rho Phyto’s medical products available.

Bryden Strokes has built a vast network and sales infrastructure in the Caribbean. With the new distribution partnership, Rho Phyto products will be available to the medical community and patients in the region, beginning with Barbados.

Not only will Avicanna be selling its modern and evidence-based products, but it will continue creating a broad education platform that focuses on patient support, marketing, and training. Canada’s Avicanna recently partnered with Medipharm labs, a leading pharmaceutical cannabis manufacturer.

With the other new partnership with Medipharm Labs, Avicanna successfully exported the first batch of products to the Caribbean, which includes oral and sublingual products. While the first products imported will be sold in Barbados, the products will be commercialized under the Medicinal Cannabis Industry Act 2019-44, which regulates how medical cannabis on the island can be handled.

Avicanna hopes that by distributing in the Caribbean, it will then expand product offerings with additional SKUs from its Canadian products. The company also hopes to expand pharmaceutical preparations from its operation in Colombia.

In a press release, the CEO of Avicanna, Aras Azadian, said that his company is very excited to expand its Rho Phyto formulary of products into Barbados through the new partnership with Bryden Stokes. Bryden Stokes “shares our vision and focus on supplying the medical community and patients with scientifically advanced and evidence-based cannabis products.,” he said. 

Azadian concluded that Avicanna is looking forward to establishing Rho Phyto as “the gold standard” throughout the Caribbean while striving to create long-term brand opportunities. 

According to Global Newswire, Bryden Stokes is happy to partner with Avicanna and offer pharmaceutical-grade medicinal cannabis to patients in Barbados, especially the evidence-based Rho Phyto brand and its many beneficial products.